Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 151–200 of 1,032 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05942001	Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)	recruiting	Phase 1	100	Jiangsu HengRui Medicine Co., Ltd.INDUSTRY	1	Aug 31, 2026	clinicaltrials
NCT06600698	Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA	recruiting	Phase 1 / Phase 2	45	Milton S. Hershey Medical CenterOTHER	1	Aug 31, 2026	clinicaltrials